A melanin-mediated cancer immunotherapy patch

Science Immunology

Volumn 2, Issue 17, 2017, Pages

  Ye, Yanqi ^a,b   Wang, Chao ^a,b   Zhang, Xudong ^a,b   Hu, Quanyin ^a,b   Zhang, Yuqi ^a,b   Liu, Qi ^a,b   Wen, Di ^a,b   Milligan, Joshua ^a   Bellotti, Adriano ^a,c   Huang, Leaf ^a,b   Dotti, Gianpietro ^c   Gu, Zhen ^a,b  

^a USA and North Carolina State University   (United States)

^b University of North Carolina   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; MELANIN;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DENDRITIC CELL; DEVICES; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; INFRARED RADIATION; KAPLAN MEIER METHOD; KNOCKOUT MOUSE; METABOLISM; NEEDLE; PATHOLOGY; PROCEDURES; TRANSDERMAL PATCH; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY; INFRARED RAYS; KAPLAN-MEIER ESTIMATE; MELANINS; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEEDLES; NEOPLASMS, EXPERIMENTAL; TRANSDERMAL PATCH; TUMOR BURDEN;

EID: 85049283109     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aan5692     Document Type: Article

References (47)

1. J. Couzin-Frankel, Cancer immunotherapy. Science 342, 1432–1433 (2013).
2. D. Ricklin, G. Hajishengallis, K. Yang, J. D. Lambris, Complement: A key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785–797 (2010).
3. J. B. Swann, M. J. Smyth, Immune surveillance of tumors. J. Clin. Invest. 117, 1137–1146 (2007).
4. L. Gu, D. J. Mooney, Biomaterials and emerging anticancer therapeutics: Engineering the microenvironment. Nat. Rev. Cancer 16, 56–66 (2015).
5. L. E. Klevorn, R. M. Teague, Adapting cancer immunotherapy models for the real world. Trends Immunol. 37, 354–363 (2016).
6. D. R. Littman, Releasing the brakes on cancer immunotherapy. Cell 162, 1186–1190 (2015).
7. C. G. Drake, E. J. Lipson, J. R. Brahmer, Breathing new life into immunotherapy: Review of melanoma, lung and kidney cancer. Nat. Rev. Clin. Oncol. 11, 24–37 (2013).
8. M. E. Dudley, S. A. Rosenberg, Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3, 666–675 (2003).
9. S. A. Rosenberg, N. P. Restifo, J. C. Yang, R. A. Morgan, M. E. Dudley, Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299–308 (2008).
10. M. T. Stephan, J. J. Moon, S. H. Um, A. Bershteyn, D. J. Irvine, Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat. Med. 16, 1035–1041 (2010).
11. B. Huang, W. D. Abraham, Y. Zheng, S. C. Bustamante López, S. S. Luo, D. J. Irvine, Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells. Sci. Transl. Med. 7, 291ra94 (2015).
12. D. J. Irvine, M. A. Swartz, G. L. Szeto, Engineering synthetic vaccines using cues from natural immunity. Nat. Mater. 12, 978–990 (2013).
13. M. F. Bachmann, G. T. Jennings, Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787–796 (2010).
14. J. Banchereau, A. K. Palucka, Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5, 296–306 (2005).
15. M. V. Dhodapkar, M. Sznol, B. Zhao, D. Wang, R. D. Carvajal, M. L. Keohan, E. Chuang, R. E. Sanborn, J. Lutzky, J. Powderly, H. Kluger, S. Tejwani, J. Green, V. Ramakrishna, A. Crocker, L. Vitale, M. Yellin, T. Davis, T. Keler, Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci. Transl. Med. 6, 232ra51 (2014).
16. A. D. Garg, L. Vandenberk, C. Koks, T. Verschuere, L. Boon, S. W. Van Gool, P. Agostinis, Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma. Sci. Transl. Med. 8, 328ra27 (2016).
17. T. R. Fadel, F. A. Sharp, N. Vudattu, R. Ragheb, J. Garyu, D. Kim, E. P. Hong, N. Li, G. L. Haller, L. D. Pfefferle, S. Justesen, K. C. Herold, T. M. Fahmy, Corrigendum: A carbon nanotube-polymer composite for T-cell therapy. Nat. Nanotechnol. 9, 723 (2014).
18. J. V. Kim, J.-B. Latouche, I. Rivière, M. Sadelain, The ABCs of artificial antigen presentation. Nat. Biotechnol. 22, 403–410 (2004).
19. C. L.-L. Chiang, G. Coukos, L. Kandalaft, Whole tumor antigen vaccines: Where are we? Vaccines 3, 344–372 (2015).
20. + T-cell priming and tumor vaccination. Proc. Natl. Acad. Sci. U.S.A. 108, 17414–17419 (2011).
21. S. B. Stephan, A. M. Taber, I. Jileaeva, E. P. Pegues, C. L. Sentman, M. T. Stephan, Biopolymer implants enhance the efficacy of adoptive T-cell therapy. Nat. Biotechnol. 33, 97–101 (2015).
22. J. Kim, W. A. Li, Y. Choi, S. A. Lewin, C. S. Verbeke, G. Dranoff, D. J. Mooney, Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat. Biotechnol. 33, 64–72 (2015).
23. O. A. Ali, D. Emerich, G. Dranoff, D. J. Mooney, In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci. Transl. Med. 1, 8ra19 (2009).
24. S. S. Evans, E. A. Repasky, D. T. Fisher, Fever and the thermal regulation of immunity: The immune system feels the heat. Nat. Rev. Immunol. 15, 335–349 (2015).
25. K. Sato, N. Sato, B. Xu, Y. Nakamura, T. Nagaya, P. L. Choyke, Y. Hasegawa, H. Kobayashi, Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy. Sci. Transl. Med. 8, 352ra110 (2016).
26. J. Fu, D. B. Kanne, M. Leong, L. H. Glickman, S. M. McWhirter, E. Lemmens, K. Mechette, J. J. Leong, P. Lauer, W. Liu, K. E. Sivick, Q. Zeng, K. C. Soares, L. Zheng, D. A. Portnoy, J. J. Woodward, D. M. Pardoll, T. W. Dubensky Jr., Y. Kim, STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci. Transl. Med. 7, 283ra52 (2015).
27. T. S. Kupper, R. C. Fuhlbrigge, Immune surveillance in the skin: Mechanisms and clinical consequences. Nat. Rev. Immunol. 4, 211–222 (2004).
28. K. Nagao, F. Ginhoux, W. W. Leitner, S.-I. Motegi, C. L. Bennett, B. E. Clausen, M. Merad, M. C. Udey, Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. U.S.A. 106, 3312–3317 (2009).
29. C. Wang, Y. Ye, G. M. Hochu, H. Sadeghifar, Z. Gu, Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 16, 2334–2340 (2016).
30. J. Yu, Y. Zhang, Y. Ye, R. DiSanto, W. Sun, D. Ranson, F. S. Ligler, J. B. Buse, Z. Gu, Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc. Natl. Acad. Sci. U.S.A. 112, 8260–8265 (2015).
31. A. Filson, J. Hope, Isolation of melanin granules. Nature 179, 211 (1957).
32. A. J. Lea, Solubility of melanins. Nature 170, 709 (1952).
33. R. Zhang, Q. Fan, M. Yang, K. Cheng, X. Lu, L. Zhang, W. Huang, Z. Cheng, Engineering melanin nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy. Adv. Mater. 27, 5063–5069 (2015).
34. S. P. Sullivan, D. G. Koutsonanos, M. del Pilar Martin, J. W. Lee, V. Zarnitsyn, S.-O. Choi, N. Murthy, R. W. Compans, I. Skountzou, M. R. Prausnitz, Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 16, 915–920 (2010).
35. M. L. Moraes, P. J. Gomes, P. A. Ribeiro, P. Vieira, A. A. Freitas, R. Kohler, O. N. Oliveira Jr., M. Raposo, Polymeric scaffolds for enhanced stability of melanin incorporated in liposomes. J. Colloid Interface Sci. 350, 268–274 (2010).
36. B. M. Carreno, V. Magrini, M. Becker-Hapak, S. Kaabinejadian, J. Hundal, A. A. Petti, A. Ly, W. R. Lie, W. H. Hildebrand, E. R. Mardis, G. P. Linette, A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 348, 803–808 (2015).
37. J. C. Castle, S. Kreiter, J. Diekmann, M. Löwer, N. van de Roemer, J. de Graaf, A. Selmi, M. Diken, S. Boegel, C. Paret, M. Koslowski, A. N. Kuhn, C. M. Britten, C. Huber, Ö. Türeci, U. Sahin, Exploiting the mutanome for tumor vaccination. Cancer Res. 72, 1081–1091 (2012).
38. A. Murshid, J. Gong, S. K. Calderwood, The role of heat shock proteins in antigen cross presentation. Front. Immunol. 3, 63 (2012).
39. M. M. Hoffmann, C. Molina-Mendiola, A. D. Nelson, C. A. Parks, E. E. Reyes, M. J. Hansen, G. Rajagopalan, L. R. Pease, A. G. Schrum, D. Gil, Co-potentiation of antigen recognition: A mechanism to boost weak T cell responses and provide immunotherapy in vivo. Sci. Adv. 1, e1500415 (2015).
40. V600E cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544–552 (2009).
41. A. Holtzhausen, F. Zhao, K. S. Evans, M. Tsutsui, C. Orabona, D. S. Tyler, B. A. Hanks, Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: Opportunities for pharmacologic enhancement of immunotherapy. Cancer Immunol. Res. 3, 1082–1095 (2015).
42. Q. Chen, L. Xu, C. Liang, C. Wang, R. Peng, Z. Liu, Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat. Commun. 7, 13193 (2016).
43. J. Conde, N. Oliva, Y. Zhang, N. Artzi, Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat. Mater. 15, 1128–1138 (2016).
44. W. Sun, Q. Hu, W. Ji, G. Wright, Z. Gu, Leveraging physiology for precision drug delivery. Physiol. Rev. 97, 189–225 (2017).
45. Y. Zhang, J. Yu, A. Kahkoska, Z. Gu, Photoacoustic drug delivery. Sensors 17, 1400 (2017).
46. L. Cheng, C. Wang, L. Feng, K. Yang, Z. Liu, Functional nanomaterials for phototherapies of cancer. Chem. Rev. 114, 10869–10939 (2014).
47. C. Wang, Y. Ye, Q. Hu, A. Bellotti, Z. Gu, Tailoring biomaterials for cancer immunotherapy: Emerging trends and future outlook. Adv. Mater. 29, 1606036 (2017).